Amrize Reports Strong 2025 Free Cash Flow, Proposes $1.0B Share Repurchase & Dividends, Issues Positive 2026 Guidance
Summary
Amrize Ltd. announced its Q4 and full-year 2025 results, featuring strong free cash flow and a significantly improved leverage ratio, alongside positive 2026 guidance and a substantial $1.0 billion share repurchase program with new dividends.
Key Events
-
Strong 2026 Financial Guidance
Amrize projects 4-6% revenue growth and 8-11% Adjusted EBITDA growth for full year 2026, reflecting accelerating customer demand.
-
Significant Shareholder Return Plan
The Board authorized a $1.0 billion share repurchase program and proposed both a special one-time dividend of $0.44 per share and an annual ordinary dividend of $0.44 per share, pending shareholder approval.
-
Improved Financial Health
The company reported strong Free Cash Flow of $1.5 billion for 2025 and reduced its Net Leverage Ratio to 1.1x as of December 31, 2025, down from 1.7x in Q3 2025.
-
Strategic Growth Initiatives
Amrize completed a 660,000-ton capacity expansion at its Ste. Genevieve cement plant and announced an agreement to acquire PB Materials, expanding its aggregates business into West Texas.
Analysis
Amrize Ltd. reported mixed financial results for Q4 and full-year 2025, with revenues slightly up for the year but Adjusted EBITDA and Net Income showing declines. However, the company demonstrated strong financial health by generating $1.5 billion in Free Cash Flow and significantly reducing its Net Leverage Ratio to 1.1x. The forward-looking 2026 guidance is robust, projecting 4-6% revenue growth and 8-11% Adjusted EBITDA growth, indicating an accelerating business outlook. Furthermore, the proposed $1.0 billion share repurchase program and new dividend plan signal strong confidence from management in future performance and a commitment to returning capital to shareholders. These capital allocation decisions, combined with strategic investments in capacity expansion and M&A, suggest a positive trajectory for the company, especially as it trades near its 52-week high.
At the time of this filing, AMRZ was trading at $59.50 on NYSE in the Manufacturing sector, with a market capitalization of approximately $31.7B. The 52-week trading range was $44.12 to $60.57. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.